Innova Captab Limited has announced its participation in an analyst and investor meeting scheduled for March 9, 2026, as part of the Investec Promoter & Founder Conference 2026. The pharmaceutical company informed stock exchanges about this engagement through a regulatory filing dated March 3, 2026.

Meeting Details and Schedule

The investor interaction is structured to facilitate comprehensive engagement between company representatives and market participants. The meeting will provide opportunities for both individual and group discussions with analysts and institutional investors.

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance and transparent information sharing practices. Innova Captab Limited has specifically stated that all discussions during the meeting will be based exclusively on publicly available information. The company has assured that no unpublished price-sensitive information will be shared with analysts or investors during these interactions.

Important Disclaimers

The pharmaceutical company has included important caveats regarding the scheduled meeting. The meeting schedule remains subject to potential changes due to exigencies that may arise from either the host organization or the company itself. This flexibility ensures that any unforeseen circumstances can be accommodated while maintaining professional engagement standards.

The announcement was signed by Neeharika Shukla, Company Secretary and Compliance Officer, demonstrating proper corporate governance protocols in investor relations activities.

Innova Captab Limited has announced an interim dividend of ₹2 per equity share for the financial year 2025-26, as approved by the Board of Directors at their meeting held on Friday, January 23, 2026. The dividend represents 20% of the face value of ₹10 each and will be payable to shareholders based on their holdings as on the record date of Friday, January 30, 2026.

Dividend Details and Record Date

The company has set the record date for determining eligible shareholders as January 30, 2026. Shareholders holding equity shares as of this date will be entitled to receive the interim dividend payment.

Tax Deduction Guidelines for Shareholders

The company has issued comprehensive guidelines regarding tax deduction at source (TDS) on the interim dividend payment. Under the Finance Act 2020 amendments to the Income Tax Act 1961, dividend income has been taxable in the hands of shareholders since April 1, 2020. Consequently, Innova Captab Limited is required to deduct TDS at the time of dividend payment.

The TDS rate varies depending on the residential status of shareholders and the documents submitted to the company. To facilitate proper TDS calculation, shareholders are requested to submit relevant documents through the designated portal at https://ris.kfintech.com/form15 by 5:00 PM IST on January 30, 2026.

Electronic Payment Mandate

In accordance with recent amendments to SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, notified on November 18, 2025, the company has informed shareholders that dividend payments will be made exclusively through electronic modes. These include:

• NEFT (National Electronic Funds Transfer)
• RTGS (Real Time Gross Settlement)
• NECS (National Electronic Clearing Service)
• Other RBI-approved electronic facilities

Action Required from Shareholders

Shareholders must ensure their bank account details are properly updated and verified to receive dividend payments. The update process varies based on how shares are held:

• Dematerialised shares: Update details with Depository Participant
• Physical shares: Update details with Company's Registrar and Share Transfer Agent

The company has emphasized the importance of updating records promptly to enable timely dividend credit and ensure compliance with the regulatory framework. Detailed communication regarding TDS provisions is available on the company's website at www.innovacaptab.com under the Tax Note section.

Source: